Covered recipient · General Payments record
SUNDAR NATARAJAN
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2020–2023
$552.85
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $212.81 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vital Connect, Inc | $51.72 | 1 |
| Novo Nordisk AS | $31.66 | 2 |
| ABBVIE INC. | $31.13 | 2 |
| Lilly USA, LLC | $30.18 | 2 |
| Sumitomo Pharma America, Inc. | $25.27 | 1 |
| Abbott Laboratories | $24.93 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.93 | 08/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018455299 | CMS |
| ABBVIE INC. | $15.53 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997989301 | CMS |
| ABBVIE INC. | $15.60 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997989303 | CMS |
| Lilly USA, LLC | $14.50 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032194865 | CMS |
| Lilly USA, LLC | $15.68 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032194871 | CMS |
| Novo Nordisk Inc | $13.87 | 08/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003075363 | CMS |
| Novo Nordisk Inc | $17.79 | 11/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003075373 | CMS |
| Sumitomo Pharma America, Inc. | $25.27 | 12/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1030827709 | CMS |
| Vital Connect, Inc | $51.72 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060264437 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.92 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056509797 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.